Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia - PubMed
Case Reports
Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia
Chun-Yu Chen et al. Clin Toxicol (Phila). 2006.
Abstract
Background: Hydroxychloroquine (HCQ) is used for treatment of lupus erythematosus. The cardiac toxicity of HCQ has focused primarily on acute intoxication. We report a case of chronic use of HCQ associated with torsade de pointes.
Case report: A 67-year-old female presented with acquired long QT interval syndrome with a refractory ventricular arrhythmia. She was receiving chronic therapeutic doses of HCQ for the treatment of lupus erythematosus. Torsades de pointes was diagnosed in the Emergency Department (ED). After excluding other causes of long QT syndrome, the HCQ was suspected as the cause of her ventricular tachycardia. After discontinuing the HCQ, the QT interval was shorter and the patient recovered after treatment with lidocaine and isoproterenol.
Conclusion: The chronic use of HCQ for rheumatic diseases, or as an anti-malarial drug, should be balanced against the risk of developing potentially lethal cardiac arrhythmias.
Similar articles
-
Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis.
Faselis C, Zeng-Treitler Q, Cheng Y, Kerr GS, Nashel DJ, Liappis AP, Weintrob AC, Karasik PE, Arundel C, Boehm D, Heimall MS, Connell LB, Taub DD, Shao Y, Redd DF, Sheriff HM, Zhang S, Fletcher RD, Fonarow GC, Moore HJ, Ahmed A. Faselis C, et al. Arthritis Rheumatol. 2021 Sep;73(9):1589-1600. doi: 10.1002/art.41803. Epub 2021 Aug 6. Arthritis Rheumatol. 2021. PMID: 33973403
-
Renaldi J, Koumpouras F, Dong X. Renaldi J, et al. Lupus. 2021 Oct;30(11):1844-1848. doi: 10.1177/09612033211034562. Epub 2021 Aug 5. Lupus. 2021. PMID: 34353174
-
Morgan ND, Patel SV, Dvorkina O. Morgan ND, et al. J Clin Rheumatol. 2013 Aug;19(5):286-8. doi: 10.1097/RHU.0b013e31829d5e50. J Clin Rheumatol. 2013. PMID: 23872551 No abstract available.
-
Hydroxychloroquine in systemic lupus erythematosus (SLE).
Ponticelli C, Moroni G. Ponticelli C, et al. Expert Opin Drug Saf. 2017 Mar;16(3):411-419. doi: 10.1080/14740338.2017.1269168. Epub 2016 Dec 14. Expert Opin Drug Saf. 2017. PMID: 27927040 Review.
-
Matsuda T, Ly NTM, Kambe N, Nguyen CTH, Ueda-Hayakawa I, Son Y, Okamoto H. Matsuda T, et al. J Dermatol. 2018 Mar;45(3):344-348. doi: 10.1111/1346-8138.14156. Epub 2017 Dec 14. J Dermatol. 2018. PMID: 29239026 Review.
Cited by
-
Hage A, de Vries M, Leffler A, Stoetzer C. Hage A, et al. J Exp Pharmacol. 2022 Nov 8;14:353-365. doi: 10.2147/JEP.S375349. eCollection 2022. J Exp Pharmacol. 2022. PMID: 36385942 Free PMC article.
-
Al Rihani SB, Smith MK, Bikmetov R, Deodhar M, Dow P, Turgeon J, Michaud V. Al Rihani SB, et al. J Clin Med. 2020 Aug 10;9(8):2591. doi: 10.3390/jcm9082591. J Clin Med. 2020. PMID: 32785135 Free PMC article.
-
Marinaki S, Tsiakas S, Korogiannou M, Grigorakos K, Papalois V, Boletis I. Marinaki S, et al. J Clin Med. 2020 Sep 16;9(9):2986. doi: 10.3390/jcm9092986. J Clin Med. 2020. PMID: 32947798 Free PMC article. Review.
-
White NJ, Watson JA, Hoglund RM, Chan XHS, Cheah PY, Tarning J. White NJ, et al. PLoS Med. 2020 Sep 3;17(9):e1003252. doi: 10.1371/journal.pmed.1003252. eCollection 2020 Sep. PLoS Med. 2020. PMID: 32881895 Free PMC article.
-
Effects of hydroxychloroquine treatment on QT interval.
Hooks M, Bart B, Vardeny O, Westanmo A, Adabag S. Hooks M, et al. Heart Rhythm. 2020 Nov;17(11):1930-1935. doi: 10.1016/j.hrthm.2020.06.029. Epub 2020 Jun 28. Heart Rhythm. 2020. PMID: 32610165 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources